Rothschild Investment LLC’s PTC Therapeutics PTCT Stock Holding History

Rothschild Investment LLC’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.3K	Buy	261 +73	+39%	+$5.27K	﹤0.01%	1532
2026 Q1	$12.8K	Buy	188 +12	+7%	+$850	﹤0.01%	1594
2025 Q4	$13.4K	Buy	176 +26	+17%	+$1.89K	﹤0.01%	1476
2025 Q3	$9.21K	Sell	150 -10	-6%	-$521	﹤0.01%	1475
2025 Q2	$7.81K	Buy	160 +20	+14%	+$949	﹤0.01%	1309
2025 Q1	$7.13K	Buy	140 +35	+33%	+$1.75K	﹤0.01%	1282
2024 Q4	$4.74K	Buy	105 +25	+31%	+$1.07K	﹤0.01%	1360
2024 Q3	$2.97K	Buy	80 +40	+100%	+$1.34K	﹤0.01%	1513
2024 Q2	$1.22K	Buy	40 +35	+700%	+$1.13K	﹤0.01%	1560
2024 Q1	$145	Buy	+5	New	+$140	﹤0.01%	1937

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Rothschild Investment LLC's PTCT Position: Q2 2026 in Review

Rothschild Investment LLC increased its PTC Therapeutics (PTCT) stake by 39% in Q2 2026, buying an estimated $5.27K and bringing the position to 261 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Rothschild Investment LLC first reported a position in PTCT in Q1 2024 and has held it in 10 quarters since. 152 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Rothschild Investment LLC held 261 shares of PTC Therapeutics worth $21.3K as of Q2 2026.
Rothschild Investment LLC bought 73 PTC Therapeutics shares in Q2 2026, an estimated $5.27K.
PTC Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1532 holding.
Rothschild Investment LLC first reported a position in PTC Therapeutics in Q1 2024 and has held it in 10 quarters since.
152 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.